Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG
Othus, M. Thomas, I. Wang, X. Ariti, C. Mehta, P. Sydenham, M. Hills, R. K. Burnett, A. K. Nand, S. Assouline, S.
Othus, M.
Thomas, I.
Wang, X.
Ariti, C.
Mehta, P.
Sydenham, M.
Hills, R. K.
Burnett, A. K.
Nand, S.
Assouline, S.
Citations
Altmetric:
Abstract
None
Description
Date
2022
Publisher
Collections
Keywords
Type
Article
Citation
Othus M, Thomas I, Wang X, Ariti C, Mehta P, Sydenham M, et al. Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leuk Lymphoma. 2022 Oct 13:1-3. PubMed PMID: 36226777. Epub 2022/10/14. eng.